hoota. I truly don't think Locke would still be mentioned in our announcements if it wasn't a certain option for us. We would have been looking elsewhere by now if it was looking 'shaky'. Locke is a safety net and not our primary funding aim by the sounds of it. Today was just a way of technically padding for time, something our Chinese mates have been elite at the last few years.
Delisting isn't the end of the world for us. if we get there. The company still holds legal title to the plots with or without the ASX. Could still sell the Company/Project.
Listing becomes important if we want to find cheaper funding.
The good news is that we find out shortly (relatively)
- Forums
- ASX - By Stock
- AVZ
- Ann: Extension of Exclusive Due Diligence Period with Locke
Ann: Extension of Exclusive Due Diligence Period with Locke, page-59
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVZ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online